Welcome to LookChem.com Sign In|Join Free

CAS

  • or
1-(4-Trifluoromethylphenyl)piperazine is a chemical compound that belongs to the class of piperazine derivatives. It is characterized by its colorless to light yellow crystalline appearance and is primarily utilized as a valuable research chemical in various scientific and pharmaceutical applications.

30459-17-7 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 30459-17-7 Structure
  • Basic information

    1. Product Name: 1-(4-TRIFLUOROMETHYLPHENYL)PIPERAZINE
    2. Synonyms: N-(4-TRIFLUOROMETHYLPHENYL)PIPERAZINE;N-(ALPHA,ALPHA,ALPHA-TRIFLUORO-P-TOLYL)PIPERAZINE;1-(ALPHA,ALPHA,ALPHA-TRIFLUORO-P-TOLYL)PIPERAZINE;1-(4-TRIFLUOROMETHYLPHENYL)PIPERAZINE;1-(4-TRIFLUOROMETHYL-PHENYL)-PIPERAZINE DIHYDROCHLORIDE;4-PIPERAZINOBENZOTRIFLUORIDE;trifluoromethylphenylpiperazine;1-(4-Trifluormethylphenyl)-piperazine
    3. CAS NO:30459-17-7
    4. Molecular Formula: C11H13F3N2
    5. Molecular Weight: 230.23
    6. EINECS: 250-210-3
    7. Product Categories: Piperidines, Piperidones, Piperazines;pharmacetical;piperazines;Building Blocks;C11;Chemical Synthesis;Heterocyclic Building Blocks
    8. Mol File: 30459-17-7.mol
  • Chemical Properties

    1. Melting Point: 88-92 °C
    2. Boiling Point: 309.1 °C at 760 mmHg
    3. Flash Point: 140.7 °C
    4. Appearance: Colorless to light yellow/Crystals
    5. Density: 1.203
    6. Vapor Pressure: 0.000654mmHg at 25°C
    7. Refractive Index: N/A
    8. Storage Temp.: N/A
    9. Solubility: soluble in Methanol
    10. PKA: 8.79±0.10(Predicted)
    11. BRN: 523408
    12. CAS DataBase Reference: 1-(4-TRIFLUOROMETHYLPHENYL)PIPERAZINE(CAS DataBase Reference)
    13. NIST Chemistry Reference: 1-(4-TRIFLUOROMETHYLPHENYL)PIPERAZINE(30459-17-7)
    14. EPA Substance Registry System: 1-(4-TRIFLUOROMETHYLPHENYL)PIPERAZINE(30459-17-7)
  • Safety Data

    1. Hazard Codes: Xi,C
    2. Statements: 36/37/38
    3. Safety Statements: 26-36
    4. WGK Germany: 3
    5. RTECS:
    6. F: 10-34
    7. HazardClass: N/A
    8. PackingGroup: N/A
    9. Hazardous Substances Data: 30459-17-7(Hazardous Substances Data)

30459-17-7 Usage

Uses

Used in Pharmaceutical Research:
1-(4-Trifluoromethylphenyl)piperazine is used as a research chemical for the development of novel pharmaceutical compounds. Its unique structure and properties make it a promising candidate for the synthesis of new drugs and therapeutic agents.
Used in Chemical Synthesis:
1-(4-Trifluoromethylphenyl)piperazine is used as a key intermediate in the synthesis of various organic compounds, particularly those with potential applications in the pharmaceutical and chemical industries. Its versatility as a building block allows for the creation of a wide range of molecules with diverse functionalities.
Used in Analytical Chemistry:
1-(4-Trifluoromethylphenyl)piperazine can be employed as a reference compound or standard in analytical chemistry, particularly in the development and validation of new analytical methods and techniques. Its distinct properties make it suitable for use in various chromatographic, spectroscopic, and other analytical procedures.

Check Digit Verification of cas no

The CAS Registry Mumber 30459-17-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,0,4,5 and 9 respectively; the second part has 2 digits, 1 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 30459-17:
(7*3)+(6*0)+(5*4)+(4*5)+(3*9)+(2*1)+(1*7)=97
97 % 10 = 7
So 30459-17-7 is a valid CAS Registry Number.
InChI:InChI=1/C11H13F3N2/c12-11(13,14)9-1-3-10(4-2-9)16-7-5-15-6-8-16/h1-4,15H,5-8H2/p+1

30459-17-7 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Aldrich

  • (80077)  1-(4-Trifluoromethylphenyl)piperazine  ≥98.0% (GC)

  • 30459-17-7

  • 80077-1G-F

  • 526.50CNY

  • Detail
  • Aldrich

  • (80077)  1-(4-Trifluoromethylphenyl)piperazine  ≥98.0% (GC)

  • 30459-17-7

  • 80077-5G-F

  • 1,597.05CNY

  • Detail

30459-17-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 11, 2017

Revision Date: Aug 11, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-[4-(trifluoromethyl)phenyl]piperazine

1.2 Other means of identification

Product number -
Other names 1-(4-TrifluoroMethylphenyl)piperazine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:30459-17-7 SDS

30459-17-7Relevant articles and documents

MONOACYLGLYCEROL LIPASE INHIBITORS

-

Paragraph 0111-0112; 0141; 0153-0154; 0189, (2021/09/09)

Provided are compounds of formula (I), or a pharmaceutically acceptable salt or solvate thereof: Also provided are compositions comprising compounds of formula (I). The compounds and compositions are also provided for use as medicaments, for example as medicaments useful in the treatment of a condition modulated by monoacylglycerol lipase (MAGL). Also provided are the use of compounds and compositions for the inhibition of monoacylglycerol lipase (MAGL).

PYRAZOLO[1,5-a]PYRIMIDIN-7(4H)-ONE INHIBITORS OF DYNEIN

-

, (2021/07/17)

Pyrazolo[1,5-a]pyrimidin-7(4H)-ones of formula (I) inhibit intraflagellar transport and are useful as anticancer agents and as probes of the function of dynein-dependent systems.

Design, synthesis, and biological evaluation of aryl piperazines with potential as antidiabetic agents via the stimulation of glucose uptake and inhibition of NADH:ubiquinone oxidoreductase

Breen, C. J.,Devine, R.,Driver, R. B.,Findlay, J. B. C.,Kelada, M.,Kinsella, G. K.,Leonard, S.,Martin, D. S. D.,Stephens, J. C.,Walsh, J. M. D.

, (2020/07/08)

The management of blood glucose levels and the avoidance of diabetic hyperglycemia are common objectives of many therapies in the treatment of diabetes. An aryl piperazine compound 3a (RTC1) has been described as a promoter of glucose uptake, in part through a cellular mechanism that involves inhibition of NADH:ubiquinone oxidoreductase. We report herein the synthesis of 41 derivatives of 3a (RTC1) and a systematic structure-activity-relationship study where a number of compounds were shown to effectively stimulate glucose uptake in vitro and inhibit NADH:ubiquinone oxidoreductase. The hit compound 3a (RTC1) remained the most efficacious with a 2.57 fold increase in glucose uptake compared to vehicle control and micromolar inhibition of NADH:ubiquinone oxidoreductase (IC50 = 27 μM). In vitro DMPK and in vivo PK studies are also described, where results suggest that 3a (RTC1) would not be expected to provoke adverse drug-drug interactions, yet be readily metabolised, avoid rapid excretion, with a short half-life, and have good tissue distribution. The overall results indicate that aryl piperazines, and 3a (RTC1) in particular, have potential as effective agents for the treatment of diabetes.

Heteroaromatic acetamide derivative, preparation and applications thereof

-

Paragraph 0030, (2019/11/04)

The present invention provides a heteroaromatic acetamide derivative, a preparation and applications thereof, wherein the derivative comprises a pharmaceutically acceptable salt and/or a solvate thereof. According to the present invention, the experiment results prove that the heteroaromatic acetamide derivative can specifically bind to transient receptor potential ankyrin 1 (TRPA1) and inhibit orreduce the activity of TRPA1, and can be used for treating diseases mediated by TRPA1; and the inhibitor of the present invention further comprises a pharmaceutical composition of the compound, and amethods for preparing the compounds. The derivative has a general formula defined in the specification.

METHODS FOR FORMING ARYL CARBON-NITROGEN BONDS USING LIGHT AND PHOTOREACTORS USEFUL FOR CONDUCTING SUCH REACTIONS

-

Paragraph 0097-0098; 0124-0125, (2019/11/22)

The disclosure relates to a method for forming aryl carbon-nitrogen bonds and to photoreactors useful in these and other light-driven reactions. The method comprises contacting an aryl halide with an amine in the presence of a Ni salt catalyst solution and an optional base, thereby forming a reaction mixture; exposing the reaction mixture to light under reaction condition sufficient to produce the aryl carbon-nitrogen bonds. In certain embodiments, the amine may be present in a molar excess to the aryl halide. In certain embodiments, the Ni salt catalyst solution includes a Ni(II) salt and a polar solvent, wherein the Ni(II) salt is dissolved in the polar solvent. In certain embodiments, the reactions conditions include holding the reaction mixture at between about room temperature and about 80° C. for between about 1 hour and about 20 hours such that at least about 50% yield is obtained.

Energy Transfer to Ni-Amine Complexes in Dual Catalytic, Light-Driven C-N Cross-Coupling Reactions

Kudisch, Max,Lim, Chern-Hooi,Thordarson, Pall,Miyake, Garret M.

supporting information, p. 19479 - 19486 (2019/12/25)

Dual catalytic light-driven cross-coupling methodologies utilizing a Ni(II) salt with a photocatalyst (PC) have emerged as promising methodologies to forge aryl C-N bonds under mild conditions. The recent discovery that the PC can be omitted and the Ni(II) complex directly photoexcited suggests that the PC may perform energy transfer (EnT) to the Ni(II) complex, a mechanistic possibility that has recently been proposed in other systems across dual Ni photocatalysis. Here, we report the first studies in this field capable of distinguishing EnT from electron transfer (ET), and the results are consistent with F?rster-type EnT from the excited state [Ru(bpy)3]Cl2 PC to Ni-amine complexes. The structure and speciation of Ni-amine complexes that are the proposed EnT acceptors were elucidated by crystallography and spectroscopic binding studies. With the acceptors known, quantitative F?rster theory was utilized to predict the ratio of quenching rate constants upon changing the PC, enabling selection of an organic phenoxazine PC that proved to be more effective in catalyzing C-N cross-coupling reactions with a diverse selection of amines and aryl halides.

C-N Cross-Coupling via Photoexcitation of Nickel-Amine Complexes

Lim, Chern-Hooi,Kudisch, Max,Liu, Bin,Miyake, Garret M.

supporting information, p. 7667 - 7673 (2018/05/31)

C-N cross-coupling is an important class of reactions with far-reaching impacts across chemistry, materials science, biology, and medicine. Transition metal complexes can elegantly orchestrate diverse aminations but typically require demanding reaction conditions, precious metal catalysts, or oxygen-sensitive procedures. Here, we introduce a mild nickel-catalyzed C-N cross-coupling methodology that operates at room temperature using an inexpensive nickel source (NiBr2·3H2O), is oxygen tolerant, and proceeds through direct irradiation of the nickel-amine complex. This operationally robust process was employed for the synthesis of diverse C-N-coupled products (40 examples) by irradiating a solution containing an amine, an aryl halide, and a catalytic amount of NiBr2·3H2O with a commercially available 365 nm LED at room temperature without added photoredox catalyst and the amine substrate serving additional roles as the ligands and base. Density functional theory calculations and kinetic isotope effect experiments were performed to elucidate the observed C-N cross-coupling reactivity.

Chrysin-piperazine conjugates as antioxidant and anticancer agents

Patel, Rahul V.,Mistry, Bhupendra,Syed, Riyaz,Rathi, Anuj K.,Lee, Yoo-Jung,Sung, Jung-Suk,Shinf, Han-Seung,Keum, Young-Soo

, p. 166 - 177 (2016/05/24)

Synthesis of 7-(4-bromobutoxy)-5-hydroxy-2-phenyl-4H-chromen-4-one intermediate treating chrysin with 1,4-dibromobutane facilitated combination of chrysin with a wide range of piperazine moieties which were equipped via reacting the corresponding amines with bis(2-chloroethyl)amine hydrochloride in diethylene glycol monomethyl ether solvent. Free radical scavenging potential of prepared products was analyzed in vitro adopting DPPH and ABTS bioassay in addition to the evaluation of in vitro anticancer efficacies against cervical cancer cell lines (HeLa and CaSki) and an ovarian cancer cell line SK-OV-3 using SRB assay. Bearable toxicity of 7a-w was examined employing Madin-Darby canine kidney (MDCK) cell line. In addition, cytotoxic nature of the presented compounds was inspected utilizing Human bone marrow derived mesenchymal stem cells (hBM-MSCs). Overall, 7a-w indicated remarkable antioxidant power in scavenging DPPH+ and ABTS++, particularly analogs 7f, 7j, 7k, 7l, 7n, 7q, 7v, 7w have shown promising free radical scavenging activity. Analogs 7j and 7o are identified to be highly active candidates against HeLa and CaSki cell lines, whereas 7h and 7l along with 7j proved to be very sensitive towards ovarian cancer cell line SKOV-3. None of the newly prepared scaffolds showed cytotoxic nature toward hBM-MSCs cells. From the structure-activity point of view, nature and position of the electron withdrawing and electron donating functional groups on the piperazine core may contribute to the anticipated antioxidant and anticancer action. Different spectroscopic techniques (FT-IR, 1H NMR, 13C NMR, Mass) and elemental analysis (CHN) were utilized to confirm the desired structure of final compounds.

Noble diamine compounds, and polyamic acid and polyamide therefrom

-

Paragraph 0098-0102, (2016/10/17)

The present invention refers to a diamine compound represented by [formula 1] and manufacturing method and. is directed at the application of. Wherein, A1 to A5 said substituent, said substituent R1 to R5 defined in the detailed description of the invention is. (by machine translation)

Pd-Catalyzed Synthesis of Piperazine Scaffolds under Aerobic and Solvent-Free Conditions

Reilly, Sean W.,Mach, Robert H.

supporting information, p. 5272 - 5275 (2016/10/31)

A facile Pd-catalyzed methodology providing an efficient synthetic route to biologically relevant arylpiperazines under aerobic conditions is reported. Electron donating and sterically hindered aryl chlorides were aminated to afford yields up to 97%, with examples using piperazine as solvent, illustrating an ecofriendly, cost-effective synthesis of these privileged structures.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 30459-17-7